StockNews.com initiated coverage on shares of ARCA biopharma (NASDAQ:ABIO – Get Rating) in a research note issued to investors on Wednesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Trading Down 2.9 % NASDAQ ABIO opened at $2.04 on Wednesday. The firm’s fifty day simple moving average is $2.07 and […]